Success Metrics

Clinical Success Rate
80.6%

Based on 100 completed trials

Completion Rate
81%(100/124)
Active Trials
8(5%)
Results Posted
38%(38 trials)
Terminated
24(15%)

Phase Distribution

Ph phase_2
19
12%
Ph early_phase_1
2
1%
Ph phase_1
10
6%
Ph phase_3
33
21%
Ph not_applicable
17
11%
Ph phase_4
68
43%

Phase Distribution

12

Early Stage

19

Mid Stage

101

Late Stage

Phase Distribution149 total trials
Early Phase 1First-in-human
2(1.3%)
Phase 1Safety & dosage
10(6.7%)
Phase 2Efficacy & side effects
19(12.8%)
Phase 3Large-scale testing
33(22.1%)
Phase 4Post-market surveillance
68(45.6%)
N/ANon-phased studies
17(11.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.5%

100 of 129 finished

Non-Completion Rate

22.5%

29 ended early

Currently Active

8

trials recruiting

Total Trials

159

all time

Status Distribution
Active(10)
Completed(100)
Terminated(29)
Other(20)

Detailed Status

Completed100
Terminated24
unknown20
Recruiting6
Withdrawn5
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
159
Active
8
Success Rate
80.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.3%)
Phase 110 (6.7%)
Phase 219 (12.8%)
Phase 333 (22.1%)
Phase 468 (45.6%)
N/A17 (11.4%)

Trials by Status

recruiting64%
withdrawn53%
unknown2013%
terminated2415%
active_not_recruiting21%
not_yet_recruiting21%
completed10063%

Recent Activity

Clinical Trials (159)

Showing 20 of 159 trialsScroll for more
NCT05085808Phase 4

RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)

Withdrawn
NCT05307003

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

Terminated
NCT05603104Phase 3

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

Recruiting
NCT06433635Phase 4

Sequential Multiple Assignment Randomized Trial for Bipolar Depression

Active Not Recruiting
NCT05973786Phase 3

The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Recruiting
NCT05590637Phase 4

Comparing Antipsychotic Medications in LBD Over Time

Recruiting
NCT04373317Phase 4

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Recruiting
NCT00457197Phase 4

Quetiapine for Bipolar Disorder and Alcohol Dependence

Completed
NCT03449472

Bariatric Surgery and Pharmacokinetics of Quetiapine

Recruiting
NCT02431702Phase 3

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform

Completed
NCT06062953Phase 2

Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia

Recruiting
NCT01119014Phase 4

Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis

Completed
NCT04521478Phase 2

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Completed
NCT04950868Phase 1

The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression

Active Not Recruiting
NCT03557931Phase 2

A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

Completed
NCT03403790

A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder

Completed
NCT06546358Early Phase 1

Quetiapine Versus Trazadone in Women With Postpartum Depression

Not Yet Recruiting
NCT00232336Phase 4

Quetiapine for Cocaine Use and Cravings

Completed
NCT02893371

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Terminated
NCT06200584Not Applicable

Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics

Completed

Drug Details

Intervention Type
DRUG
Total Trials
159